Hybrid ablation
Hybrid ablation is a medical procedure with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hybrid Therapy and Heart Team for Atrial Fibrillation
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation
Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation
Two-stage Hybrid Ablation or Thoracoscopic Epicardial Ablation for Long-standing Persistent Atrial Fibrillation
Clinical Trials (6)
Hybrid Therapy and Heart Team for Atrial Fibrillation
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation
Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation
Two-stage Hybrid Ablation or Thoracoscopic Epicardial Ablation for Long-standing Persistent Atrial Fibrillation
Hybrid Versus Catheter Ablation in Persistent AF
All 6 trials loaded
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 6